A private equity firm based in the USA makes investments for majority or significant minority equity stakes in mature, middle-market companies in the healthcare sector. The firm typically invests $5-20 million in companies valued between $10-100 million. The firm invests in both privately held and publicly traded companies and primarily invests in the USA and Canada.
The firm focuses on healthcare IT, specialty medical devices and products, healthcare services and pharma distribution/supply chain. The firm will consider all opportunities in these fields that match the firm’s financial criteria, and has experience of investing in skincare, enterprise HCIT, hearing devices and wearable devices. The firm only invests in companies with products/services that are on the market and with revenues of at least $5 million per year.
The firm focuses on companies with revenues of $5-75 million, valuations from $10-100 million, and EBITDA from near break-even up to $15 million. The firm is interested in buyouts, recapitalizations, and opportunities to work alongside founders to scale and improve a company. The firm has the expertise to assist companies in accessing US healthcare markets.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.
Next Phase Newsletter 
Leave a Reply